This trial is testing a new, MR-guided 3D ultrasound technique to see if it can more effectively treat prostate cancer while sparing the surrounding nerves and vessels.
1 Primary · 5 Secondary · Reporting Duration: Until study completion with 5 years of follow up
Experimental Treatment
10 Total Participants · 1 Treatment Group
Primary Treatment: Low dose rate (LDR) brachytherapy · No Placebo Group · N/A
Age 18 - 75 · Male Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: